Differential effects of typical and atypical neuroleptics on alpha-noradrenergic and dopaminergic post synaptic receptors.
D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D002540:Cerebral Cortex / Q000378:metabolism; D003000:Clonidine / Q000378:metabolism; D003342:Corpus Striatum / Q000378:metabolism; D006220:Haloperidol / Q000378:metabolism; D006719:Homovanillic Acid / Q000378:metabolism; D008297:Male; D009830:Olfactory Bulb / Q000378:metabolism; D010879:Piperazines / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects*; D011954:Receptors, Dopamine / Q000187:drug effects*
D014150:Antipsychotic Agents; D010879:Piperazines; D011743:Pyrimidines; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D011954:Receptors, Dopamine; D006220:Haloperidol; D003000:Clonidine; D006719:Homovanillic Acid